⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
prnewswire.com
ABBV
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
prnewswire.com
ABBV
Antibody Therapeutics Market worth $597.1 billion by 2035 - Exclusive Report by MarketsandMarkets™
prnewswire.com
ABBV
MRK
BMY
JNJ
AMGN
REGN
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
globenewswire.com
GMAB
ABBV
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
globenewswire.com
GMAB
ABBV
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
businesswire.com
GMAB
ABBV
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
Global Leaders, Fortune 500 CEOs and Tech Visionaries Convene in Chicago for Second Annual Global Quantum Forum
prnewswire.com
MSFT
CTSH
EXC
IBM
GOOG
JPM
ALL
SO
ABBV
UL
BAC
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
prnewswire.com
ABBV